JACQUELINE RIVAS: Open Payments
NPI 1427704840 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 31 payments from 6 companies in 2025. Trend: 2023 $239 · 2024 $788 · 2025 $717
Food & beverage: $627Education: $90
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 20 | $250 |
| Astellas Pharma US Inc | 4 | $158 |
| PFIZER INC. | 2 | $129 |
| Janssen Biotech, Inc. | 2 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Eisai Inc. | 1 | $30 |
Products named: CABOMETYX, PADCEV, ERLEADA, Xtandi, Nubeqa, Lenvima.
Industry payments across TX — which companies pay providers there.
